CBM header new
 

Please feel free to forward to colleagues and fellow researchers and share news of our journal

CBM 21 web

Indexed in: PubMed/MEDLINE Web of Science Scopus

NEW ISSUE

Dear Colleague,

In this mailing, we share the latest issue of Cancer Biomarkers (Volume 34, Issue 3). In this newsletter, we also announce the new Journal Impact Factor, highlight the most read recent content, and provide details of how to submit your research to the journal.

Kind regards,

Editor-in-Chief
Sudhir Srivastava, PhD, MPH
submissions@iospress.com

CBM red-bar

NEW ISSUE

Volume 34, Issue 3 / 2022 / Available Online

RESEARCH ARTICLES
Effect of D-mannose on Philadelphia chromosome-positive leukemia cells
Okabe, Seiichi | Tanaka, Yuko | Gotoh, Akihiko

Comparison of CINtec PLUS cytology and cobas HPV test for triaging Canadian patients with LSIL cytology referred to colposcopy: A two-year prospective study
Gilbert, Laura | Ratnam, Sam | Jang, Dan | Alaghehbandan, Reza | Schell, Miranda | Needle, Rob | Ecobichon-Morris, Anne | Wadhawan, Arnav | Costescu, Dustin | et al.

Clinical powers of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma
Li, Yixue | Liu, Hengrui

Exosome-delivered circular RNA DLGAP4 induces chemoresistance via miR-143-HK2 axis in neuroblastoma
Tan, Wei-Qiang | Yuan, Li | Wu, Xiao-Yan | He, Cheng-Guang | Zhu, Shai-Cheng | Ye, Ming

Prognostic significance of a complement factor H autoantibody in early stage NSCLC
Gottlin, Elizabeth B. | Campa, Michael J. | Gandhi, Rikesh | Bushey, Ryan T. | Herndon 2nd, James E. | Patz Jr., Edward F.

Identifying glycolysis-related LncRNAs for predicting prognosis in breast cancer patientsOpen Access
Zou, Jiayue | Gu, Yanlin | Zhu, Qi | Li, Xiaohua | Qin, Lei

miR-370 is better than miR-375 as a non-invasive diagnostic biomarker for pediatric acute myeloid leukemia patients
Ali, Mona Mostafa | Mohamed, Rania Hassan | Sayed, Ahmed A. | Ahmed, Sonia | Yassin, Dina A. | El-Sayed, Wael M.

Diagnosis and staging of HCV associated fibrosis, cirrhosis and hepatocellular carcinoma with target identification for miR-650, 552-3p, 676-3p, 512-5p and 147b
Gibriel, Abdullah Ahmed | Ismail, Manal Fouad | Sleem, Hameis | Zayed, Naglaa | Yosry, Ayman | El-Nahaas, Saeed M. | Shehata, Nagwa Ibrahim

MiR-224 promotes lymphatic metastasis by targeting ANGPTL1 in non-small-cell lung carcinoma
Han, Haibo | Pan, Bo | Liang, Fan | Wu, Lina | Liu, Xijuan | Yang, Yue | Chen, Jinfeng

HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis
Zhang, Li | Zhao, Yao | Guan, Hao | Zhang, Di

CBM red-bar

Impact Factor News

CBM Impact Factor: 3.828

CBM IF-trend-graph visual Jun2022

Image Credit: Journal Citation Reports

CBM has a new Journal Impact Factor of 3.828 according to the just-released 2021 Journal Citation Reports (Source: Clarivate, 2022). The number of citations to papers published in CBM continues to be high. The journal is listed in the Oncology category of Science Citation Index Expanded (SCIE).

We thank our authors, reviewers and readers for the continuing success of CBM.

CBM red-bar

Most Read CBM Articles in May 2022

Listing the top viewed articles (all published in 2022) via the IOS Press Content Library

Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images (Research Article in Vol.33, Iss.2, 2022) – Openly Available
Qureshi, Touseef Ahmad | Gaddam, Srinivas | Wachsman, Ashley Max | Wang, Lixia | Azab, Linda | Asadpour, Vahid | Chen, Wansu | Xie, Yibin | Wu, Bechien | Pandol, Stephen Jacob | Li, Debiao

Volume doubling time and radiomic features predict tumor behavior of screen-detected lung cancers (Research Article in Vol.33, Iss.4, 2022) – Openly Available
Pérez-Morales, Jaileene | Lu, Hong | Mu, Wei | Tunali, Ilke | Kutuk, Tugce | Eschrich, Steven A. | Balagurunathan, Yoganand | Gillies, Robert J. | Schabath, Matthew B.

Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery (Research Article in Vol.33, Iss.2, 2022) – Openly Available
Mikdadi, Dina | O’Connell, Kyle A. | Meacham, Philip J. | Dugan, Madeleine A. | Ojiere, Michael O. | Carlson, Thaddeus B. | Klenk, Juergen A.

Targeted proteomics for cancer biomarker verification and validation (Research Article in Vol.33, Iss.4, 2022) – Openly Available
Ogata, Seiryo | Masuda, Takeshi | Ito, Shingo | Ohtsuki, Sumio

Multi-OMICs data analysis identifies molecular features correlating with tumor immunity in colon cancer (Research Article in Vol.33, Iss.2, 2022) – Openly Available
Elsayed, Inas | Elsayed, Nazik | Feng, Qiushi | Sheahan, Kieran | Moran, Bruce | Wang, Xiaosheng

CBM red-bar

Call For Papers

Publish Where Your Work Will Be Noticed

Submit Today!

As a member of our research community, we would like to invite you to contribute your own articles to the journal.

There are many benefits for contributing authors, including rigorous peer review and rapid processing and online publication (pre-press), and an affordable open access option.

Submit your manuscript online
View the Instructions for Authors
View list of Editorial Board
View full journal contents

CBM red-bar

Please Share Cancer Biomarker News With Your Colleagues

Help Spread News of CBM!

If you know of any colleagues or fellow researchers who are not yet signed up to receive news from Cancer Biomarkers, we invite you to share this mailing with them.

Click on the visual or access the sign-up link here.

CBM red-bar
***

You are receiving this mailing as you are signed up to receive news from CBM.
You can unsubscribe or alter your preferences at any time by clicking the links below
.

If you would like to receive more NEWS FROM IOS PRESS, go here

 
 
Powered by Mad Mimi®A GoDaddy® company